pharma news

News

US anti-vaccine rhetoric trumpeted in UK, thanks to Reform

Experts have pushed back against anti-vaccine comments made by an advisor to the Trump administration at the Reform UK conference.

News

Heather Turner, LB Pharma's chief executive.

After a long biotech IPO lull, LB Pharma chances its arm

After a promising start, IPOs all but fizzled out this year, but LB Pharma is hoping that won't stymy its chances of completing a Nasdaq listing.

News

Novartis nabs cardio drug with $1.4bn Tourmaline buy

Novartis has bulked up in cardiology with a $1.4bn takeover of Tourmaline Bio and its drug for atherosclerotic cardiovascular disease (ASCVD).

News

Mixed data from lung cancer trials on show at WCLC

Highlights of the WCLC show include new data for AstraZeneca's Tagrisso, Summit's ivonescimab, MSD/Daiichi's I-DXd, and BMS/Systimmune's iza-bren.

News

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.

News

NRG raises £50m to start trials of Parkinson's, ALS drug

NRG Therapeutics' oversubscribed Series B will fund first-in-human trials of a drug targeting mitochondrial dysfunction in neurodegenerative diseases.

US anti-vaccine rhetoric trumpeted in UK, thanks to Reform

After a long biotech IPO lull, LB Pharma chances its arm

Novartis nabs cardio drug with $1.4bn Tourmaline buy

Mixed data from lung cancer trials on show at WCLC

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

NRG raises £50m to start trials of Parkinson's, ALS drug

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks